Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides

J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e833-e835. doi: 10.1111/jdv.19922. Epub 2024 Mar 12.

Ingrid Lazaridou^{1

2}, Mohammed Alqahtani¹, Baptiste Louveau^{2

3

4}, Caroline Ram-Wolff¹, Bader Alharbi⁵, Jana Al Hage¹, Maëlle Dumont¹, Jean-David Bouaziz^{1

2

3}, Martine Bagot^{1

2}, Hélène Moins-Teisserenc^{3

6

7}, Jacqueline Rivet⁸, Maxime Battistella^{2

3

8}, Samia Mourah^{2

3

4}, Adèle de Masson^{1

2

3}

¹ Department of Dermatology, APHP, Saint-Louis University Hospital, Paris, France.
² INSERM U976, Institut de Recherche Saint-Louis, Paris, France.
³ Université Paris Cité, Paris, France.
⁴ Pharmacology and Solid Tumor Genomics, APHP, Saint-Louis University Hospital, Paris, France.
⁵ King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
⁶ Hematology Laboratory, APHP, Saint-Louis University Hospital, Paris, France.
⁷ INSERM U1160, Institute de Recherche Saint-Louis, Paris, France.
⁸ Department of Pathology, APHP, Saint-Louis University Hospital, Paris, France.

No abstract available

Publication types